SupplementaryTable1.xlsx from COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers
Introduction: Huntington’s disease (HD) is considered a rare and fatal neurodegenerative disease; despite that, only one study described the outcomes among those with HD and COVID-19. In this context,
This FAIRsharing record describes: This registry is designed to capture pediatric and adult COVID-19 cases that are occurring across the world in patients living with sickle cell disease. The goal of
CN: Myeloma Cast Nephropathy;LCDD: Light Chain Deposition Disease; MM: Multiple Myeloma; AKI: acute kidney injury. Values are mean ±SD or median (range)* 1 subject had two distinct episodes of AKIOne